236 related articles for article (PubMed ID: 18567823)
1. Deletion of cd39/entpd1 results in hepatic insulin resistance.
Enjyoji K; Kotani K; Thukral C; Blumel B; Sun X; Wu Y; Imai M; Friedman D; Csizmadia E; Bleibel W; Kahn BB; Robson SC
Diabetes; 2008 Sep; 57(9):2311-20. PubMed ID: 18567823
[TBL] [Abstract][Full Text] [Related]
2. Disordered purinergic signaling and abnormal cellular metabolism are associated with development of liver cancer in Cd39/ENTPD1 null mice.
Sun X; Han L; Seth P; Bian S; Li L; Csizmadia E; Junger WG; Schmelzle M; Usheva A; Tapper EB; Baffy G; Sukhatme VP; Wu Y; Robson SC
Hepatology; 2013 Jan; 57(1):205-16. PubMed ID: 22859060
[TBL] [Abstract][Full Text] [Related]
3. CD39 limits P2X7 receptor inflammatory signaling and attenuates sepsis-induced liver injury.
Savio LEB; de Andrade Mello P; Figliuolo VR; de Avelar Almeida TF; Santana PT; Oliveira SDS; Silva CLM; Feldbrügge L; Csizmadia E; Minshall RD; Longhi MS; Wu Y; Robson SC; Coutinho-Silva R
J Hepatol; 2017 Oct; 67(4):716-726. PubMed ID: 28554875
[TBL] [Abstract][Full Text] [Related]
4. Vascular CD39/ENTPD1 directly promotes tumor cell growth by scavenging extracellular adenosine triphosphate.
Feng L; Sun X; Csizmadia E; Han L; Bian S; Murakami T; Wang X; Robson SC; Wu Y
Neoplasia; 2011 Mar; 13(3):206-16. PubMed ID: 21390184
[TBL] [Abstract][Full Text] [Related]
5. Disordered purinergic signaling inhibits pathological angiogenesis in cd39/Entpd1-null mice.
Jackson SW; Hoshi T; Wu Y; Sun X; Enjyoji K; Cszimadia E; Sundberg C; Robson SC
Am J Pathol; 2007 Oct; 171(4):1395-404. PubMed ID: 17823293
[TBL] [Abstract][Full Text] [Related]
6. Natural killer T cell dysfunction in CD39-null mice protects against concanavalin A-induced hepatitis.
Beldi G; Wu Y; Banz Y; Nowak M; Miller L; Enjyoji K; Haschemi A; Yegutkin GG; Candinas D; Exley M; Robson SC
Hepatology; 2008 Sep; 48(3):841-52. PubMed ID: 18752325
[TBL] [Abstract][Full Text] [Related]
7. Regulated catalysis of extracellular nucleotides by vascular CD39/ENTPD1 is required for liver regeneration.
Beldi G; Wu Y; Sun X; Imai M; Enjyoji K; Csizmadia E; Candinas D; Erb L; Robson SC
Gastroenterology; 2008 Nov; 135(5):1751-60. PubMed ID: 18804472
[TBL] [Abstract][Full Text] [Related]
8. Purinergic dysregulation in pulmonary hypertension.
Visovatti SH; Hyman MC; Goonewardena SN; Anyanwu AC; Kanthi Y; Robichaud P; Wang J; Petrovic-Djergovic D; Rattan R; Burant CF; Pinsky DJ
Am J Physiol Heart Circ Physiol; 2016 Jul; 311(1):H286-98. PubMed ID: 27208163
[TBL] [Abstract][Full Text] [Related]
9. Disordered pancreatic inflammatory responses and inhibition of fibrosis in CD39-null mice.
Künzli BM; Nuhn P; Enjyoji K; Banz Y; Smith RN; Csizmadia E; Schuppan D; Berberat PO; Friess H; Robson SC
Gastroenterology; 2008 Jan; 134(1):292-305. PubMed ID: 18036594
[TBL] [Abstract][Full Text] [Related]
10. The vascular ectonucleotidase ENTPD1 is a novel renoprotective factor in diabetic nephropathy.
Friedman DJ; Rennke HG; Csizmadia E; Enjyoji K; Robson SC
Diabetes; 2007 Sep; 56(9):2371-9. PubMed ID: 17473221
[TBL] [Abstract][Full Text] [Related]
11. Preservation of cochlear function in Cd39 deficient mice.
Vlajkovic SM; Housley GD; Thorne PR; Gupta R; Enjyoji K; Cowan PJ; Charles Liberman M; Robson SC
Hear Res; 2009 Jul; 253(1-2):77-82. PubMed ID: 19327391
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effects of CD39/ecto-nucleoside triphosphate diphosphohydrolase-1 in murine intestinal ischemia-reperfusion injury.
Guckelberger O; Sun XF; Sévigny J; Imai M; Kaczmarek E; Enjyoji K; Kruskal JB; Robson SC
Thromb Haemost; 2004 Mar; 91(3):576-86. PubMed ID: 14983235
[TBL] [Abstract][Full Text] [Related]
13. Targeted deletion of ectonucleoside triphosphate diphosphohydrolase 1/CD39 leads to desensitization of pre- and postsynaptic purinergic P2 receptors.
Schaefer U; Machida T; Broekman MJ; Marcus AJ; Levi R
J Pharmacol Exp Ther; 2007 Sep; 322(3):1269-77. PubMed ID: 17565006
[TBL] [Abstract][Full Text] [Related]
14. EGFR tyrosine kinase inhibitor (PD153035) improves glucose tolerance and insulin action in high-fat diet-fed mice.
Prada PO; Ropelle ER; Mourão RH; de Souza CT; Pauli JR; Cintra DE; Schenka A; Rocco SA; Rittner R; Franchini KG; Vassallo J; Velloso LA; Carvalheira JB; Saad MJ
Diabetes; 2009 Dec; 58(12):2910-9. PubMed ID: 19696185
[TBL] [Abstract][Full Text] [Related]
15. Deletion of CD39 on natural killer cells attenuates hepatic ischemia/reperfusion injury in mice.
Beldi G; Banz Y; Kroemer A; Sun X; Wu Y; Graubardt N; Rellstab A; Nowak M; Enjyoji K; Li X; Junger WG; Candinas D; Robson SC
Hepatology; 2010 May; 51(5):1702-11. PubMed ID: 20146261
[TBL] [Abstract][Full Text] [Related]
16. Vascular stasis, intestinal hemorrhage, and heightened vascular permeability complicate acute portal hypertension in cd39-null mice.
Sun X; Cárdenas A; Wu Y; Enjyoji K; Robson SC
Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G306-11. PubMed ID: 19520738
[TBL] [Abstract][Full Text] [Related]
17. Western diet modulates insulin signaling, c-Jun N-terminal kinase activity, and insulin receptor substrate-1ser307 phosphorylation in a tissue-specific fashion.
Prada PO; Zecchin HG; Gasparetti AL; Torsoni MA; Ueno M; Hirata AE; Corezola do Amaral ME; Höer NF; Boschero AC; Saad MJ
Endocrinology; 2005 Mar; 146(3):1576-87. PubMed ID: 15591151
[TBL] [Abstract][Full Text] [Related]
18. NTPDase1 governs P2X7-dependent functions in murine macrophages.
Lévesque SA; Kukulski F; Enjyoji K; Robson SC; Sévigny J
Eur J Immunol; 2010 May; 40(5):1473-85. PubMed ID: 20201036
[TBL] [Abstract][Full Text] [Related]
19. Tuning the Thromboinflammatory Response to Venous Flow Interruption by the Ectonucleotidase CD39.
Anyanwu AC; Kanthi Y; Fukase K; Liao H; Mimura T; Desch KC; Gruca M; Kaskar S; Sheikh-Aden H; Chi L; Zhao R; Yadav V; Wakefield TW; Hyman MC; Pinsky DJ
Arterioscler Thromb Vasc Biol; 2019 Apr; 39(4):e118-e129. PubMed ID: 30816804
[TBL] [Abstract][Full Text] [Related]
20. CD39/ENTPD1 expression by CD4+Foxp3+ regulatory T cells promotes hepatic metastatic tumor growth in mice.
Sun X; Wu Y; Gao W; Enjyoji K; Csizmadia E; Müller CE; Murakami T; Robson SC
Gastroenterology; 2010 Sep; 139(3):1030-40. PubMed ID: 20546740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
